Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL30330321 | 0.98 | TP53 (0.44) | TP53HDAC1HDAC4KDM4EHTT | |
| SCHEMBL29251756 | 0.89 | CA2 (0.38) | TP53KDM4EHTTLMNASMN1; SMN2 | |
| SCHEMBL29251759 | 0.89 | CYP2D6 (0.39) | TP53KDM4EHTTLMNASMN1; SMN2 | |
| SCHEMBL29659675 | 0.88 | HTT (0.46) | KDM4EHTTLMNASMN1; SMN2 | |
| SCHEMBL902375 | 0.88 | HTT (0.46) | KDM4EHTTLMNASMN1; SMN2 | |
| Acetic Acid SCHEMBL30330689 | 0.88 | LMNA (0.39) | TP53KDM4EHTTLMNASMN1; SMN2 | |
| SCHEMBL4070618 | 0.86 | HTT (0.53) | HTTLMNASMN1; SMN2 | |
| Bromide SCHEMBL384486 | 0.86 | KDM4E (0.46) | KDM4EHTTLMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2833307 | 0.86 | RAD52 (0.46) | HDAC1HDAC4HTTSMN1; SMN2 | |
| SCHEMBL18538799 | 0.86 | TP53 (0.44) | TP53HDAC1HDAC4KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024142789-A1 | GOLD ELECTROPLATING SOLUTION AND METHOD FOR PRODUCING GOLD-ELECTROPLATED COATING | 日本高純度化学株式会社 | 2024-07-04 | — | — | WO | disclosed |
| CN-106661735-B | Palladium plating solution and palladium coating film obtained using the same | 日本高纯度化学株式会社 | 2019-12-10 | — | — | CN | disclosed |
| US-20170050996-A1 | ANTIOXIDANT COMPOUNDS AND THEIR USE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2017-02-23 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050996-A1 | ANTIOXIDANT COMPOUNDS AND THEIR USE | HMOX1, PPOX, LPO | TP53 3374/4885HDAC1 718/4885HDAC4 748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.